CLINICAL_TRIALS
trial_result
· 2014-12-22
Clinical Trial Update: PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam) [Phase 4]
Summary
Phase 4 pharmacofMRI study evaluating the brain response to alprazolam in individuals with anxiety disorders; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Anxiety Disorders | Phase 4 | Status: COMPLETED | Results posted: 2014-12-22